Loading clinical trials...
Loading clinical trials...
A Non-interventional Study of HLA-DRB1*04:01 Distribution in Adults With Recently Diagnosed Type 1 Diabetes (T1D)
Conditions
Interventions
blood draw
Locations
5
United States
University of California, San Francisco
San Francisco, California, United States
University of Florida- Gainesville
Gainesville, Florida, United States
Joslin Diabetes Center
Boston, Massachusetts, United States
Icahn School of Medicine at Mount Sinai
New York, New York, United States
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Start Date
June 6, 2025
Primary Completion Date
January 30, 2026
Completion Date
June 1, 2026
Last Updated
September 18, 2025
NCT07011147
NCT06688331
NCT02081326
NCT02088658
NCT06945744
NCT00306098
Lead Sponsor
GentiBio, Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions